berberine has been researched along with Nervous System Disorders in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) is a well-known phytochemical isolated from a number of medicinal herbs." | 2.82 | Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms. ( Shaw, PC; Shou, JW, 2022) |
| "Berberine (BBR) has gained attention for its vast beneficial biological effects through immunomodulation, anti-inflammatory and anti-apoptosis properties." | 1.38 | Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability. ( Cao, X; Cui, L; Dong, L; Ji, Y; Li, Y; Liu, Z; Qiao, H; Wang, C; Wang, L; Xing, Y; Zhang, X; Zhao, K; Zhu, C, 2012) |
| "As berberine is a natural compound that has been safely administered to humans, it opens up new perspectives for the treatment of neuropsychiatric diseases." | 1.34 | The natural product berberine is a human prolyl oligopeptidase inhibitor. ( Giralt, E; Kichik, N; Seguí, J; Tarrago, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shou, JW | 1 |
| Shaw, PC | 1 |
| Zhang, X | 2 |
| Wang, C | 1 |
| Li, Y | 1 |
| Dong, L | 1 |
| Cui, L | 1 |
| Wang, L | 1 |
| Liu, Z | 1 |
| Qiao, H | 1 |
| Zhu, C | 1 |
| Xing, Y | 1 |
| Cao, X | 1 |
| Ji, Y | 1 |
| Zhao, K | 1 |
| Tarrago, T | 1 |
| Kichik, N | 1 |
| Seguí, J | 1 |
| Giralt, E | 1 |
1 review available for berberine and Nervous System Disorders
| Article | Year |
|---|---|
Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms.
Topics: Berberine; Humans; Nervous System Diseases | 2022 |
2 other studies available for berberine and Nervous System Disorders
| Article | Year |
|---|---|
Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability.
Topics: Animals; Berberine; Blood-Brain Barrier; Brain Edema; Cerebral Infarction; CREB-Binding Protein; Dis | 2012 |
The natural product berberine is a human prolyl oligopeptidase inhibitor.
Topics: Berberine; Binding Sites; Biological Products; Humans; Magnetic Resonance Spectroscopy; Medicine, Ch | 2007 |